Skip to content

Rivaroxaban EP Impurity D

Rivaroxaban EP Impurity D

Product Description
CAT No.
ALN-R017018
CAS No.
1365267-35-1
Mol. F.
C29H32N6O9
Mol. Wt.
608.6
Stock
In Stock
Chemical Name : N,N′-bis[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]urea (as per EP);1,3-Bis({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)urea (as per USP)
Smiles : O=C(NC[C@H]1CN(C2=CC=C(N3C(COCC3)=O)C=C2)C(O1)=O)NC[C@H]4CN(C5=CC=C(N6C(COCC6)=O)C=C5)C(O4)=O
Inchi : InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m1/s1
Synonym : Rivaroxaban USP Related Compound D ; Rivaroxaban Urea Dimer

Development and validation of stability indicating UPLC method for the determination of Rivaroxaban in bulk and finished products and identification of degradation products by LCMS

By Ali, Syed Mastan; Ramachandran, D.nFrom Journal of Applicable Chemistry (Lumami, India) (2021), 10(3), 291-301

Validated LC-MS/MS method for the determination of three genotoxic impurities in rivaroxaban drug substance

By Korlakunta, Vijaya Gouri; Dasari, Vijaya Bharathi; Sharma, Hemant Kumar; Nowduri, Annapurna; Bonige, Kishore Babu; Chavakula, Ramadas – From European Journal of Biomedical and Pharmaceutical Sciences (2020), 7(8), 492-500

Development of a stability-indicating HPLC method and a dissolution test for rivaroxaban dosage forms

By Souri, Effat; Mottaghi, Siavash; Zargarpoor, Mohammad; Ahmadkhaniha, Reza; Jalalizadeh, Hassan – From Acta Chromatographica (2016), 28(3), 347-361

Request For Quotation